Medical Condition News

RSS

Acquired immune thrombotic thrombocytopenic purpura develops after vaccination with CoronaVac

Researchers from the Second Affiliated Hospital of Nanjing Medical University, et al. have published a case report entitled "Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac". This report was published in Frontiers of Medicine, Volume 18, Issue 4, 2024.

17 Nov 2025

Study uncovers how tumors exploit a molecular signal to exhaust T cells

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them-and how silencing that signal could revive the body's immunity.

17 Nov 2025

Parental postpartum depression linked to higher autism risk

Findings reveal a strong link between parental postpartum depression and autism risk, stressing the importance of mental health support for new parents.

17 Nov 2025

Low-glutamate diet improves migraine symptoms in veterans with Gulf War Illness

Veterans with Gulf War Illness experienced significant improvement in migraine symptoms after following a diet low in glutamate, a component of flavor enhancing food additives commonly found in processed foods, according to new research presented by Georgetown University and American University scientists.

17 Nov 2025

Chronic pain in adults linked to increased risk of developing high blood pressure

Chronic pain in adults may increase their risk of high blood pressure, and the location and extent of pain and if they also had depression were contributing factors, according to new research published today in Hypertension, an American Heart Association journal.

17 Nov 2025

Gut microbes may fuel allergic rhinitis symptoms

The study identifies gut microbiome alterations in allergic rhinitis, suggesting a gut-nose axis that could inform new treatment approaches for this condition.

17 Nov 2025

Study highlights need for XDP specific diagnostic assays

Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve diagnosis for X-linked dystonia-parkinsonism (XDP), a rare and disabling movement disorder that affects primarily men of Filipino ancestry.

17 Nov 2025

New therapy restores vision after stroke induced blindness

Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the "vertical midline"). Hemianopia severely affects daily activities such as reading, driving, or just walking through a crowded space.

17 Nov 2025

Low-intensity noise therapy shows how tuning sound to the brain can ease tinnitus

LINTS, a non-masking low-intensity noise tuned to each patient’s tinnitus frequency, produced statistically significant but modest reductions in tinnitus burden in a phase II clinical trial. Improvements were confined to the treatment-only group, with high individual variability and strong dependence on precise acoustic fitting.

16 Nov 2025

Are mushrooms more than a low-calorie food? New analysis explains their hidden advantages

Whole mushroom consumption shows consistent benefits for cardiometabolic health, lowering triglycerides in self-chosen diets and improving fasting glucose in a single healthy dietary pattern trial. Early evidence also suggests increases in salivary IgA and possible blood pressure improvements, with no adverse biomarker effects reported.

16 Nov 2025

Preclinical study shows aged garlic extract improves memory and reduces anxiety

Long-term aged garlic extract supplementation improved specific anxiety-related behaviors and enhanced memory and learning in aging mice. Proteomic profiling revealed extensive hippocampal and cortical molecular changes linked to synaptic signaling, neuroplasticity, and stress-response pathways.

16 Nov 2025

Dash diet cuts diabetes complications by targeting blood pressure kidney health and inflammation

The DASH diet supports metabolic health in people with diabetes by improving blood pressure, renal function, lipids, and modest glycemic markers while reducing risks linked to vascular and inflammatory pathways. Its broad nutrient-driven mechanisms also benefit related conditions such as neuropathy, PCOS, and retinopathy, making it a versatile tool for cardiometabolic care.

16 Nov 2025

Johns Hopkins study links mild pancreatic duct dilatation to higher cancer risk

Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the United States by 2030, according to the National Institutes of Health (NIH).

14 Nov 2025

WHO releases first global guidelines for managing diabetes during pregnancy

The World Health Organization (WHO) today released its first global guidelines for the management of diabetes during pregnancy, a condition affecting about one in six pregnancies – or 21 million women annually.

14 Nov 2025

Testing nicotinamide riboside as a potential aid for long COVID recovery

Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in eClinicalMedicine, "Effects of Nicotinamide Riboside on NAD+ Levels, Cognition, and Symptom Recovery in Long-COVID: A Randomized Controlled Trial."

14 Nov 2025

Higher melanoma rates linked to agricultural areas in Pennsylvania

Counties in Pennsylvania that contained or were near cultivated cropland had significantly higher melanoma rates compared to other regions, according to a new study led by scientists at Penn State.

14 Nov 2025

Synthesizing a powerful cancer-fighting molecule from sea sponges

Yale chemists have synthesized a complex, potentially cancer-fighting molecule found in sea sponges discovered off the coast of South Korea.

14 Nov 2025

Fondazione Telethon achieves milestone with Waskyra approval for Wiskott-Aldrich Syndrome

Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending marketing authorization in the European Union for Waskyra, an ex vivo gene therapy for Wiskott-Aldrich Syndrome (WAS), a rare and life-threatening primary immunodeficiency.

14 Nov 2025

DeepTarget: A new tool for drug repurposing in oncology

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology.

14 Nov 2025

MD Anderson launches historic $2.5 billion campaign to end cancer

The University of Texas MD Anderson Cancer Center today launches its historic $2.5 billion comprehensive philanthropic campaign, Only Possible Here, The Campaign to End Cancer.

14 Nov 2025